Darbelife 100 Injection (Darbepoetin Alfa Injection 100 mcg)

Darbelife 100 Injection is a branded pharmaceutical product containing darbepoetin alfa, a long-acting erythropoiesis-stimulating agent (ESA). Presented as a prefilled syringe, Darbelife 100 Injection is developed for regulated pharmaceutical supply chains and professional use environments. AmeriDrugs supplies this product strictly for export to licensed importers, distributors, hospitals, and pharmacies operating under prescription-based regulatory frameworks.

Active Ingredient (API + Strength)

• Active Pharmaceutical Ingredient: Darbepoetin Alfa

• Strength: 100 mcg per 0.5 ml

• Dosage Form: Prefilled syringe, sterile solution

Therapeutic Use (Informational, Non-Advisory)
Darbepoetin alfa is a recombinant erythropoietin analog used in regulated clinical settings to support red blood cell production under specific, approved medical conditions. Darbelife 100 Injection is supplied for use in accordance with locally approved therapeutic protocols and regulatory guidance. Information provided here is for product identification and regulatory understanding only and does not constitute medical advice or treatment recommendations.

Dosage Form & Route of Administration

• Dosage Form: Sterile solution in prefilled syringe

• Routes of Administration: Subcutaneous or intravenous (as per approved protocols)

• Prescription Status: Prescription-only medicine

• Intended for professional handling within regulated pharmaceutical channels

Quality & Manufacturing Standards
Darbelife 100 Injection is manufactured following current Good Manufacturing Practices (GMP) and established biopharmaceutical quality systems. The manufacturing process includes validated controls for sterility, protein integrity, and product stability. Each batch undergoes stringent quality testing to meet export and regulatory requirements applicable to international markets.

Packaging Information (Export-Oriented)

• Primary Packaging: Single-dose prefilled syringe (0.5 ml)

• Secondary Packaging: Printed carton with regulatory labeling

• Packaging suitable for temperature-controlled international distribution

• Export labeling and documentation support available based on destination market regulations

Target Buyers

• Licensed pharmaceutical importers and distributors

• Hospital pharmacies and institutional healthcare providers

• Retail and wholesale pharmacies operating under prescription regulations

• Government and private healthcare procurement agencies

• International suppliers specializing in injectable biologics

Regulatory & Compliance Note
Darbelife 100 Injection is a prescription-only biological medicine intended for regulated pharmaceutical distribution. Not for direct consumer self-use. Product supply is subject to import authorization, local drug regulatory approval, and applicable healthcare compliance requirements in the destination country. AmeriDrugs adheres to international export compliance and documentation standards.